Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

# Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 **What the Bill Would Do** This bill, officially titled the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025, aims to address uterine fibroids—noncancerous tumors that grow in the uterus and affect many women. While the full details aren't publicly available yet, bills with this title typically focus on improving diagnosis, treatment options, and research funding for uterine fibroids and related gynecological health issues. **Who It Affects** The bill would primarily affect women who suffer from uterine fibroids, which are particularly common among Black women and women of reproductive age. It could also impact healthcare providers, researchers studying gynecological conditions, and the broader medical system by potentially expanding coverage or treatment access. **Current Status** As of now, HR 4392 remains in committee and has not been passed.

The bill was introduced by Representative Shontel M. Brown (D-OH). Like most bills at this early stage, it would need committee review, potential amendments, and votes in both the House and Senate before becoming law.